Weight-loss drugs to remain on Wada monitoring list but not banned for 2027
Wada will revisit its position at next year’s executive committee meeting
Full story
Read the full story at The Independent ↗
Continue reading this story on The Independent, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.
